Galapagos enters partnership with Gilead for autoimmune drug development
Go back to Galapagos enters partnership with Gilead for autoimmune drug development| Gilead Sciences (NASDAQ: GILD) | Delayed: 139.02 +0.66 (0.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $138.36 | 52 Week High | $108.63 | |||
| Open | $138.36 | 52 Week Low | $71.39 | |||
| Day High | $139.49 | P/E | 76.81 | |||
| Day Low | $136.63 | EPS | $1.81 | |||
| Volume | 1,874,823 | |||||
| (NASDAQ: GLPG) | Delayed: 27.73 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.73 | 52 Week High | $73.37 | |||
| Open | $27.73 | 52 Week Low | $37.03 | |||
| Day High | $27.73 | P/E | N/A | |||
| Day Low | $27.73 | EPS | $0.00 | |||
| Volume | 123,060 | |||||
